Upcoming world debut will mark a step forward in AI-powered hematology and advance fourth-generation hematology analysis
Anaheim, California and Frankfurt, Germany, June 29, 2026 /PRNewswire/ — Ozelle will introduce its latest automated blood analyzer, the O-Cyte 1, at ADLM 2026 in California. Making its global debut at one of the major international events in diagnostic and laboratory medicine, O-Cyte 1 marks Ozelle’s latest milestone in advancing fourth-generation hematology analysis through AI × CBM (Complete Blood Morphology).
Ozelle will introduce its latest automated blood analyzer, the O-Cyte 1, at ADLM.
For decades, cell morphology has been one of the most valuable sources of insight into hematology. However, incorporating morphology into routine hematology workflows without reducing productivity remains a challenge. While manual microscopy relies on expert knowledge, image-based approaches are expanding the range of what laboratories can observe, but do not necessarily fit seamlessly into routine high-throughput workflows.
O-Cyte 1 is designed to address this gap by combining morphological intelligence, scalable throughput, and operational simplicity into one compact system. Built on Ozelle’s AI × CBM technology, this analyzer transforms cellular images into structured morphological insights, supporting workflows that move beyond numerical parameters toward image-based evidence and consistent interpretation.
Designed for productive clinical workflows, O-Cyte 1 supports up to 60 tests per hour as a standalone unit and up to 360 tests per hour with cascading expansion. The compact footprint, modular architecture, minimal maintenance workflow, and service-ready design are intended to help healthcare providers and laboratory operators increase efficiency while reducing operational complexity.
“O-Cyte 1 reflects our vision to make advanced morphological intelligence more practical, scalable, and accessible to everyday hematology workflows,” said Raymond, head of Ozelle North America. “At ADLM, we look forward to showing our global partners how AI-powered morphology can move into more productive hematology workflows.”
At ADLM 2026, Ozelle will introduce O-Cyte 1 along with its clinical hematology portfolio. With the growing demand for efficient and scalable hematology solutions in North America, Europe, the Middle East, Southeast Asia, India, and beyond, Ozelle aims to support diverse clinical settings with AI-powered diagnostic systems designed for daily clinical practice.
Visitors and partners can experience O-Cyte 1 at booth 2517 during ADLM 2026, July 28-30 at the Anaheim Convention Center. Partners who cannot attend in person can request a product briefing or explore local collaboration opportunities.
Contact Ozel
www.ozellemed.com
[email protected]
